麦澜德(688273) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was ¥104,336,800.77, representing a decrease of 4.39% compared to the same period last year[5] - Net profit attributable to shareholders was ¥36,286,016.09, an increase of 12.04% year-on-year[5] - The net profit after deducting non-recurring gains and losses was ¥33,674,390.42, reflecting a growth of 24.67% compared to the previous year[5] - Basic earnings per share for the period were ¥0.3660, up by 13.00% year-on-year[5] - Operating profit for Q1 2024 increased to CNY 42,049,025.98, up 11.8% from CNY 37,804,558.77 in Q1 2023[17] - Net profit for Q1 2024 was CNY 38,187,419.68, compared to CNY 33,393,575.58 in Q1 2023, reflecting a growth of 14.1%[17] - The net profit for Q1 2024 was ¥38,187,419.68, an increase of 14.5% compared to ¥33,393,575.58 in Q1 2023[20] - The net profit attributable to shareholders of the parent company was ¥36,286,016.09, up from ¥32,386,135.75, reflecting a growth of 12.5%[20] - Basic and diluted earnings per share for Q1 2024 were both ¥0.3660, compared to ¥0.3239 in Q1 2023, marking an increase of 12.9%[20] Cash Flow - The net cash flow from operating activities decreased significantly by 81.26%, amounting to ¥4,058,727.37, primarily due to increased cash payments related to marketing and research collaborations[6][7] - Cash flow from operating activities generated a net amount of ¥4,058,727.37, a significant decrease from ¥21,662,232.00 in the previous year[22] - The company reported a decrease in cash flow from operating activities, with cash outflows totaling ¥92,463,811.67, compared to ¥86,196,630.42 in Q1 2023[22] - Cash inflow from investment activities totaled ¥358,611,236.61, down from ¥1,115,521,237.42 in Q1 2023[22] - The net cash flow from investment activities was ¥2,634,197.55, a recovery from a negative cash flow of -¥343,914,611.50 in the same period last year[23] - The total cash and cash equivalents at the end of Q1 2024 stood at ¥986,737,394.28, compared to ¥852,593,085.72 at the end of Q1 2023[23] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,554,514,503.61, a slight increase of 1.34% from the end of the previous year[6] - Total assets increased to CNY 1,554,514,503.61 as of March 31, 2024, compared to CNY 1,533,923,915.26 at the end of 2023[14] - Total liabilities decreased to CNY 148,420,113.65 in Q1 2024 from CNY 158,603,955.36 in Q4 2023[15] Research and Development - Research and development expenses totaled ¥12,949,133.49, accounting for 12.41% of operating revenue, which is an increase of 1.3 percentage points[6] - Research and development expenses for Q1 2024 were CNY 12,949,133.49, compared to CNY 12,127,378.83 in Q1 2023, indicating a focus on innovation[17] Government Subsidies - The company received government subsidies amounting to ¥1,548,743.58, which are closely related to its normal business operations[7] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 4,112[9] Inventory and Goodwill - The company reported a significant increase in inventory, which stood at CNY 50,145,979.93 as of March 31, 2024, down from CNY 55,016,492.55 at the end of 2023[13] - The company’s goodwill increased significantly to CNY 50,831,751.31 as of March 31, 2024, from CNY 908,485.32 at the end of 2023, suggesting recent acquisitions or investments[14] Market Activity - The company has not reported any new product launches or significant market expansions during this quarter[20] - There were no acquisitions or mergers reported in the current financial period[20]